Use of the CONSORT Statement and Quality of Reports of Randomized Trials
JAMAPublished 18 April 2001
David Moher, Alison Jones, Leah Lepage, for the CONSORT Group
Citations1,018
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Use of the Consolidated Standards for Reporting of Trials (CONSORT) statement is associated with improvements in the quality of reports of RCTs.
Abstract
Use of the CONSORT statement is associated with improvements in the quality of reports of RCTs.
Keywords
Decision SciencesMedicineEconomics, Econometrics and Finance
Controlled Clinical TrialsAssessing the quality of reports of randomized clinical trials: Is blinding necessary?
17,565 Citations1996Alejandro R. Jadad, R Andrew Moore +5 more
An instrument to assess the quality of reports of randomized clinical trials (RCTs) in pain research is described and its use to determine the effect of rater blinding on the assessments of quality is described.
Medical Entomology and ZoologyExperimental and Quasi-Experimental Designs for Research
15,238 Citations1963Donald T. Campbell, Julian C. Stanley +1 more
JAMAEmpirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
5,580 Citations1995Klaus‐Peter Schulz
Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
The LancetDoes quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
3,591 Citations1998David Moher, Ba’ Pham +6 more
Study of low methodological quality in which the estimate of quality is incorporated into the meta-analyses can alter the interpretation of the benefit of intervention, whether a scale or component approach is used in the assessment of trial quality.
JAMAImproving the quality of reporting of randomized controlled trials. The CONSORT statement
3,343 Citations1996Colin B. Begg
BMJBetter reporting of randomised controlled trials: the CONSORT statement
614 Citations1996Douglas G. Altman
It is entirely reasonable to require higher standards for papers reporting randomised trials than those describing other types of study, since randomised controlled trials are the best way to compare the effectiveness of different interventions.
The LancetDoes blinding of readers affect the results of meta-analyses?
483 Citations1997Jesse A. Berlin
JAMAValue of Flow Diagrams in Reports of Randomized Controlled Trials
310 Citations2001Matthias Egger
Flow diagrams are associated with improved quality of reporting of randomized controlled trials, and the structure of current flow diagrams is less than ideal, so a revised flow diagram is proposed that includes all important counts through the stages of parallel group trials.
BMJThe case for structuring the discussion of scientific papers
183 Citations1999Michael Docherty, Richard Smith
Structure is important so that readers don't become lost and a strong structure allows readers to know where to look for particular information and makes it more likely that all important information will be included.
JAMADiscussion Sections in Reports of Controlled Trials Published in General Medical Journals
159 Citations1998Mike Clarke, Iain Chalmers
There is little evidence that journals have adequately implemented the CONSORT recommendation that results of an RCT be discussed in light of the totality of the available evidence.
JAMABeyond CONSORT: Need for Improved Reporting Standards for Clinical Trials
64 Citations1998Curtis L. Meinert
There is no point in randomizing persons to treatment if the assignment is ameliorated or ignored in the analysis, and there are no withdrawals (fifth tier of boxes) from trials after randomization under the intention-to-treat analysis construct.